High Pointe Capital Management’s Novo Nordisk NVO Stock Holding History

High Pointe Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$253K	Sell	4,560 -6,180	-58%	-$317K	0.18%	72
2021 Q4	$601K	Hold	10,740	–	–	0.4%	71
2021 Q3	$516K	Hold	10,740	–	–	0.41%	70
2021 Q2	$450K	Sell	10,740 -1,320	-11%	-$51.2K	0.35%	74
2021 Q1	$407K	Buy	12,060 +440	+4%	+$15.7K	0.36%	68
2020 Q4	$406K	Hold	11,620	–	–	0.38%	68
2020 Q3	$403K	Hold	11,620	–	–	0.49%	63
2020 Q2	$380K	Hold	11,620	–	–	0.5%	58
2020 Q1	$350K	Buy	11,620 +540	+5%	+$16.1K	0.5%	55
2019 Q4	$321K	Hold	11,080	–	–	0.38%	66
2019 Q3	$286K	Hold	11,080	–	–	0.39%	70
2019 Q2	$283K	Sell	11,080 -3,000	-21%	-$74.1K	0.4%	70
2019 Q1	$368K	Hold	14,080	–	–	0.5%	73
2018 Q4	$324K	Sell	14,080 -720	-5%	-$16K	0.53%	64
2018 Q3	$349K	Hold	14,800	–	–	0.47%	66
2018 Q2	$341K	Buy	+14,800	New	+$352K	0.49%	66

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

High Pointe Capital Management's NVO Position: Q1 2022 in Review

High Pointe Capital Management reduced its Novo Nordisk (NVO) stake by 58% in Q1 2022, selling an estimated $317K and leaving 4,560 shares worth $253K. The position accounts for 0.18% of the portfolio, ranked #72.

High Pointe Capital Management first reported a position in NVO in Q2 2018 and has held it in 16 quarters since. The position peaked at $601K in Q4 2021. 903 funds tracked by Wall St. Rank hold NVO as of Q1 2022.

High Pointe Capital Management held 4,560 shares of Novo Nordisk worth $253K as of Q1 2022.
High Pointe Capital Management sold 6,180 Novo Nordisk shares in Q1 2022, an estimated $317K.
Novo Nordisk made up 0.18% of High Pointe Capital Management's portfolio in Q1 2022, its #72 holding.
High Pointe Capital Management first reported a position in Novo Nordisk in Q2 2018 and has held it in 16 quarters since.
High Pointe Capital Management's Novo Nordisk position peaked at $601K in Q4 2021.
903 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2022.

Based on High Pointe Capital Management's 13F filing for Q1 2022, filed 10 May 2022.